Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
0.191
-0.009 (-4.60%)
At close: Apr 28, 2026, 4:00 PM EDT
0.195
+0.004 (2.20%)
After-hours: Apr 28, 2026, 5:11 PM EDT
Ernexa Therapeutics Market Cap
Ernexa Therapeutics has a market cap or net worth of $5.56 million as of April 28, 2026. Its market cap has decreased by -51.95% in one year.
Market Cap
5.56M
Enterprise Value
4.44M
1-Year Change
-51.95%
Ranking
Category
Stock Price
$0.19
Market Cap Chart
Since March 26, 2021, Ernexa Therapeutics's market cap has decreased from $197.28M to $5.56M, a decrease of -97.18%. That is a compound annual growth rate of -50.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 5.83M | -38.09% |
| Dec 31, 2025 | 9.42M | -37.64% |
| Dec 31, 2024 | 15.10M | 55.53% |
| Dec 29, 2023 | 9.71M | -41.17% |
| Dec 30, 2022 | 16.51M | -92.39% |
| Dec 31, 2021 | 217.02M | 10.01% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Purple Biotech | 6.23M |
| CollPlant Biotechnologies | 6.00M |
| BioRestorative Therapies | 5.86M |
| Aptevo Therapeutics | 5.76M |
| Mustang Bio | 5.71M |
| PMGC Holdings | 5.48M |
| Jaguar Health | 5.45M |
| Cardio Diagnostics Holdings | 5.39M |